First GLP-1 analog liraglutide: the result of clinical trails on efficacy
This review analytically considers the results of clinical trials on efficacy and safety and clinical perspectives of GLP-1 analog liraglutide
Saved in:
Main Authors: | Alexander Sergeevich Ametov, Lyudmila Leonidovna Kamynina |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/fadfb6f4534043718b50e3d267ba37a6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
by: Alexander Sergeevich Ametov, et al.
Published: (2011) -
The role of human glucagon-like peptide-1 analog in therapy of type 2 dianetes mellitus
by: Marina Vladimirovna Shestakova
Published: (2010) -
Combined insulin detemir and liraglutide therapy in type 2 diabetic patients: a base for an alliance
by: Lyudmila Alexandrovna Ruyatkina, et al.
Published: (2017) -
Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
by: Campbell RK, et al.
Published: (2010) -
Experience of the use of liraglutide (Victoza) in women with type 2 diabetes mellitus and obesity
by: Vladimir Ivanovich Kudinov, et al.
Published: (2011)